OnSight Lead Gen
Turn Every Showing Into Closings. OnSight LeadGen is the complete open house and real estate lead capture system built for modern agents and broker t
About this Tool
Turn Every Showing Into Closings.
OnSight LeadGen is the complete open house and real estate lead capture system built for modern agents and broker t
OnSight LeadGen is the complete open house and real estate lead capture system built for modern agents and broker teams.
Replace paper sign-in sheets with AI-powered conversations, smart QR code campaigns, instant entry notifications, automated SMS and email follow-up, digital business tools, and built-in safety.
From first scan to signed documents, LeadGen helps you capture more buyers and convert faster.
AI Property Host™ – Conversational Sign-Ins
Transf
🔍 People also searched for
Pros & Cons
✓ Pros
- ✓Free plan available
✗ Cons
- ✗No Android app available
- ✗No web or desktop version
📋 Scripts & Prompts for OnSight Lead Gen
Copy these AI-powered scripts to get maximum value from this tool. Sign up free to copy.
No scripts added for this tool yet.
Browse all this niche scripts in the Vault →🔌 MCP Servers for OnSight Lead Gen
Connect these MCP servers to give Claude, Cursor & Cline superpowers with this tool. Sign up free to copy install commands.
No MCP servers added for this tool yet.
Browse all this niche MCP servers →🤖 AI Agents for OnSight Lead Gen
Pre-built automation agents that work with this tool — import in one click. Sign up free to access.
No agents added for this tool yet.
Browse all this niche agents in the Hub →Similar this niche Tools
Tags
Frequently Asked Questions
OnSight Lead Gen is available as free. Visit the tool's website for the latest pricing details and plan options.
OnSight Lead Gen offers a free plan. Check the website for feature limitations and upgrade options.
OnSight Lead Gen is available on iOS. Check the official website for the latest platform support.
Many tools offer free trials to let you test before subscribing. Check the OnSight Lead Gen website for current trial availability and duration.